European Prostate Cancer Therapeutics Market
“The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is
constantly changing, offering industry participants many new market
opportunities.”
Key features
• Quality Analysis of the European LHRH and Anti-Androgen Therapeutics Market
• The most in depth Analysis available of the European Brachytherapy Seeds Market
• Coverage of Emerging Therapies• Strong Focus on Market Challenges & Strategies
VOICE OVER TIPS
• make sure the bullet points stand up on their own• raise the most salient points and talk knowledgably around
each one!• Target time 30 - 40 seconds
Key content: Revenue Forecasts & Competitive Analysis
Total Prostate Cancer Therapeutics Market: Revenue Forecasts (Europe), 1998 - 2008
0
200
400
600
800
1000
1200
1400
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Year
Re
ve
nu
es ($m
)
Market Size and Forecast
Segmentation: LHRH Analogs, Anti-Androgens Brachytherapy Seeds
Market Share Analysis- European & Country Levels
Featured Companies
• AstraZeneca• Takeda• Ipsen Biotech• Schering Ag• Amersham Health
What to do next
For more informationCall 44 20 7343 8342 or
Prostate Cancer Therapeutics is part of the Global Oncology
Subscription www.pharma.frost.com